CN112778288A - 一种近红外固态发光的荧光探针及其制备方法与应用 - Google Patents
一种近红外固态发光的荧光探针及其制备方法与应用 Download PDFInfo
- Publication number
- CN112778288A CN112778288A CN202110089529.5A CN202110089529A CN112778288A CN 112778288 A CN112778288 A CN 112778288A CN 202110089529 A CN202110089529 A CN 202110089529A CN 112778288 A CN112778288 A CN 112778288A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- fluorescent probe
- dichloromethane
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 210000004027 cell Anatomy 0.000 claims abstract description 28
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 24
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 claims abstract description 22
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 claims abstract description 22
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims abstract description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 93
- 238000006243 chemical reaction Methods 0.000 claims description 40
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000007787 solid Substances 0.000 claims description 21
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 12
- 230000035484 reaction time Effects 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 12
- 229940125904 compound 1 Drugs 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 claims description 10
- 229940125782 compound 2 Drugs 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- 229940126214 compound 3 Drugs 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 229940125898 compound 5 Drugs 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000005086 pumping Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- DNRVZOZGQHHDAT-UHFFFAOYSA-N 2-amino-5-chlorobenzamide Chemical compound NC(=O)C1=CC(Cl)=CC=C1N DNRVZOZGQHHDAT-UHFFFAOYSA-N 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 5
- YYROCZQCWNIJNV-UHFFFAOYSA-N n-methylpiperidin-2-amine Chemical compound CNC1CCCCN1 YYROCZQCWNIJNV-UHFFFAOYSA-N 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000012043 crude product Substances 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000523 sample Substances 0.000 abstract description 17
- 238000011065 in-situ storage Methods 0.000 abstract description 15
- 238000010186 staining Methods 0.000 abstract description 5
- 230000004044 response Effects 0.000 abstract description 3
- 238000009792 diffusion process Methods 0.000 abstract description 2
- 229920006395 saturated elastomer Polymers 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 238000010859 live-cell imaging Methods 0.000 abstract 1
- 238000004020 luminiscence type Methods 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 description 20
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 5
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域
本发明属于荧光探针技术领域,具体涉及一种近红外固态发光的荧光探针及其制备方法与应用。
背景技术
细胞膜表面的蛋白酶活性对细胞的生长、分化以及细胞间的交流都有着极其重要的作用,然而目前能用于细胞膜表面蛋白酶的原位成像手段依然有很大的局限性。过去的几十年中,小分子荧光探针已经广泛应用于生物目标物的检测和成像。然而,已有的荧光探针大多是基于脂溶性染料设计的,由于细胞膜具有两亲性的特点,探针在细胞膜经过酶水解后释放的染料很容易进入细胞内,从而呈现假信号,失去酶活性的原位成像信息。
固态荧光团因其极差的水溶性,目前已经实现了一部分生物标记物的原位成像。然而其本身激发和发射波长较短,在进行生物成像的时候存在背景荧光的干扰,另一方面其本身具有一定的脂溶性,不适合用于细胞膜表面相关酶的原位成像。因此,开发一种具有强疏水性,弱脂溶性和近红外荧光的固态荧光团用于细胞膜表面相关酶的原位成像具有极其重要的意义。
谷氨酰转肽酶(GGT)是一种细胞膜锚定的胞外酶,主要负责将细胞外的谷胱甘肽转化为半胱氨酸用来维持细胞正常的氧化还原平衡。在肿瘤,炎症等多种疾病中,GGT活性均有明显提高。因此,在细胞膜表面长时原位的成像膜表面相关蛋白酶对于研究疾病的发生,发展和治疗都有着非常重要的意义,然而,目前并没有一个有效的检测成像手段可以实现细胞膜表面GGT的原位成像。
发明内容
本发明的目的是提供一种弱脂溶性,强疏水性近红外固态发光的荧光探针及其制备方法与应用;可以解决传统荧光探针在细胞成像过程中容易扩散造成假阳性信号的问题,提高荧光成像对比度的技术问题。
本发明这种近红外固态发光的荧光探针,其结构式如式Ⅰ所示:
本发明这种近红外固态发光的荧光探针的制备方法,包括以下步骤:
(1)将化合物1和乌洛托品溶于三氟乙酸中,加热条件下进行回流反应,反应结束后,加入盐酸进行水解反应,反应结束后,过柱分离后,得到黄色中间体化合物2;
(2)将步骤(1)中的化合物2与2-氨基-5-氯苯甲酰胺及对甲苯磺酸在无水乙醇溶剂中进行回流反应,反应结束并冷却后,向其中加入二氯二氰基苯醌,然后抽滤,得到红色的固体,用乙醇洗涤固体,烘干即得固态荧光染料HYPQ;
(3)将化合物3溶于二氯甲烷中,在冰浴条件下加入DCC,进行初级反应,反应结束后,接着加入2-甲氨基哌啶,并渐渐升温至室温,进行反应,反应完毕后,抽滤掉生成的固体,滤液旋干,饱和碳酸氢钠水溶液洗,二氯甲烷萃取,再调节pH到2~4,产物在水中,再将pH调到11~13,二氯甲烷萃取,旋干,泵0.5~2h,得到化合物4;
(4)在氮气保护下,将步骤(2)中HYPQ溶于无水二氯甲烷和二甲亚砜中,在冰浴条件下中,加入DIPEA,并搅拌混匀,接着加入三光气,常温下搅拌反应,反应完毕后,真空泵抽出未反应的光气;化合物4溶于无水二氯甲烷后加入反应体系,接着加入DIPEA继续反应,反应完毕后,将反应液进行萃取收集有机相,有机相干燥后减压旋蒸去掉萃取溶剂,得到粗产物化合物5,用二氯甲烷重新溶解化合物5,接着向其中加入三氟乙酸脱保护基,刮板提纯产物,得到式Ⅰ所示的近红外固态发光的荧光探针;
合成路线如下:
所述步骤(1)中,化合物1、乌洛托的物质的量之比为1:(1~1.5),化合物1 与三氟乙酸的质量体积比为15~16mg/mL;加热温度为85~95℃,回流反应时间为2~4h;盐酸的浓度为11~13mol/L,相对化合物1的加入量为:150~160mg化合物1加入3~4mL盐酸,水解反应时间为0.5~1.5h;过柱分离采用体积比为5:(3~1) 二氯甲烷和石油醚。
所述步骤(2)中,化合物2、2-氨基-5-氯苯甲酰胺、对甲苯磺酸和二氯二氰基苯醌的物质的量之比为1:(1~1.5):(0.01~0.02):(1.5~3);化合物2与无水乙醇的质量体积比为1~2mg/mL;回流反应时间为2~4h,回流反应温度为80~85℃。
所述步骤(3)中,化合物3,DCC和2-甲氨基哌啶的物质的量之比为1:(1~ 1.2):(1~1.1);化合物3与二氯甲烷的质量体积比为3~6mg/mL;初级反应时间为 10~20min;反应时间为15~17h。
所述步骤(4)中,HYPQ,三光气和化合物4的物质的量之比为1:4:(1~1.1);二氯甲烷和二甲亚砜体积比为9~11:1,HYPQ与二氯甲烷和二甲亚砜混合溶剂的质量体积比为0.5~2mg/mL;HYPQ与第一次加入DIPEA的质量体积比为 48~50mg/mL,HYPQ与第二次加入DIPEA的质量体积比48~50mg/mL;搅拌混匀时间为9~12min,常温下搅拌反应时间为10~14h;化合物4溶于二氯甲烷后的浓度为8~10mg/mL;继续反应时间为10~14h。
所述的近红外固态发光的荧光探针在检测体外缓冲液中酶活性中的应用。
所述的近红外固态发光的荧光探针作为检测活细胞中成像细胞膜表面谷氨酰转肽酶活性中检测试剂中的应用。
本发明的原理:本发明首先合成了一种新型强疏水性弱脂溶性近红外固态荧光染料HYPQ是一个基于分子内质子转移机理的固态荧光染料,其荧光性质可以通过对其羟基保护与去保护来调控;然后利用HYPQ合成了GTT成像荧光探针 HYPQG(式Ⅰ结构所示),所述荧光探针HYPQG具有较好的水溶性,荧光探针与谷氨酰转肽酶反应后,释放出荧光团HYPQ,由于强疏水和弱脂溶性的特点使其很容易沉淀在细胞膜表面,产生很强的固态荧光信号。该荧光探针与谷氨酰转肽酶反应后能够在原位生成沉淀,荧光信号很难扩散,实现对细胞膜相关蛋白酶的原位检测和高对比度、高分辨的荧光成像。
本发明的有益效果:
1)本发明式Ⅰ结构所示荧光探针具有固态近红外发光性质,能够有效降低背景荧光信号,减少生物体自体荧光干扰,提高探针的灵敏度;
2)本发明式Ⅰ结构所示荧光探针对谷氨酰转肽酶的响应快速,30min内能够响应饱和;
3)本发明式Ⅰ结构所示荧光探针对谷氨酰转肽酶的选择性好;
4)本发明式Ⅰ结构所示荧光探针对活细胞染色效果很好,染色时间较短,染色效率高;
5)本发明式Ⅰ结构所示荧光探针能够实现细胞膜表面谷氨酰转肽酶的原位检测;
6)本发明式Ⅰ结构所示荧光探针光稳定性好,在活细胞成像中荧光信号稳定,不扩散。
附图说明
图1为实施例1制备的荧光探针的荧光发射光谱随着谷氨酰转肽酶活性增加的变化曲线,横坐标为波长(nm),纵坐标为荧光发射强度。
图2为实施例1制备的荧光探针与谷氨酰转肽酶反应后生成沉淀的DLS和 SEM表征图。
图3为实施例1制备的荧光探针相对于之前文献报道的荧光探针用于细胞膜表面谷氨酰转肽酶成像的共聚焦成像的对比图。
图4为实施例1制备的荧光探针对活细胞染色后的实时共聚焦成像图。
图5为实施例1制备的荧光探针对不同肿瘤细胞的内源性谷氨酰转肽酶的共聚焦成像图。
图6为实施例1制备的荧光探针对于同一细胞在不同的刺激条件下的细胞膜表面谷氨酰转肽酶的共聚焦成像图。
具体实施方式
下面结合具体实例对本发明作进一步阐述,但本发明并不限于以下实施例。所述方法如无特别说明均为常规方法,所述原料如无说明均能从公开商业途径获得。
实施例1近红外抗扩散细胞膜成像探针HYPQG的合成
本实施例的合成路线如下,具体包括以下步骤:
(1)将化合物1(156mg)和乌洛托品(84mg)溶于三氟乙酸(10mL)中,加热(90℃)回流下3h,反应结束后,加入4mL浓度为12mol/L的盐酸进行水解反应1h,然后以二氯甲烷和石油醚为洗脱剂,将反应液进行过柱分离,得到黄色中间体(34mg,20%)化合物2;
(2)将化合物2(34mg)、2-氨基-5-氯苯甲酰胺(25mg)及对甲苯磺酸(0.1 mg)在60mL无水乙醇中82℃回流搅拌3h,冷却后加入二氯二氰基苯醌(35mg),抽滤得到红色的固体,用乙醇洗涤固体,烘干即得到纯净的红色化合物(14.2mg, 29%),即弱脂溶性近红外固态荧光染料即(E)-2-(2-(3-(6-氯-4-氧代-3,4- 二氢喹唑啉)-4-羟基苯乙烯基)-4H)丙二腈,命名为HYPQ;
HYPQ的质谱及核磁表征:
1H NMR(400MHz,DMSO-d6)δ8.7–8.7(m,1H),8.6(s,1H),8.1(s,1H),7.9 (s,2H),7.9–7.8(m,4H),7.8–7.7(m,2H),7.6(d,J=7.9Hz,1H),7.4(s,1H),7.1 (d,J=8.8Hz,1H),6.9(s,1H).13C NMR(101MHz,DMSO-d6 and pyridine-d5)δ 189.9,182.4,172.8,161.2,155.6,147.6,136.5,135.4,134.6,134.2,132.8,130.0, 128.9,125.4,124.7,124.2,123.2,122.7,121.8,115.4,44.2.
ESI/MS,m/z:calc.490.9,found 489.3.[M-]
核磁和质谱与合成路线的结构式是完全对应的。
(3)将化合物3(303mg)溶于60mL二氯甲烷中,在冰浴条件下加入DCC(227 mg),反应15min,加入2-甲氨基哌啶(114mg)渐渐升至室温反应16h,抽滤掉生成的固体,滤液旋干,饱和碳酸氢钠水溶液洗,二氯甲烷萃取,再调节pH到3,产物在水中,再将pH调到12,二氯甲烷萃取,旋干,泵1h,得到化合物4(164mg, 41%)。
(4)在氮气保护下,将HYPQ(49mg)溶于50mL无水二氯甲烷和5mL二甲亚砜中,在冰浴中加入1mL DIPEA搅拌10min,然后缓慢加入三光气(124mg),常温下搅拌反应12h。真空泵抽调未反应的光气,化合物4(80mg)溶于8mL无水二氯甲烷加入反应体系,接着加入1mLDIPEA继续反应12h;将反应液进行萃取收集有机相,有机相干燥后减压旋蒸去掉萃取溶剂,得到粗产物化合物5,用二氯甲烷重新溶解化合物5,加入十倍当量三氟乙酸脱保护基,刮板提纯产物,得到GGT固态荧光探针,命名为HYPQG。
质谱及核磁表征:
1H NMR(400MHz,DMSO-d6)δ8.73(d,J=8.3Hz,1H),8.55(s,1H),8.16(s, 1H),8.11(s,1H),7.94(t,J=8.1Hz,3H),7.91–7.85(m,1H),7.83–7.78(m,1H), 7.72(d,J=8.7Hz,1H),7.68–7.53(m,2H),7.40(s,1H),7.06(s,1H),4.12–3.96 (m,1H),3.79(s,1H),3.72(s,1H),3.65(s,1H),3.51(s,1H),2.94(s,3H),2.25(s, 2H),1.98(s,2H),1.51(s,4H),1.45(s,2H).
13C NMR(101MHz,DMSO-d6)δ158.24,153.40,152.49,150.60,137.39, 136.03,135.13,132.53,131.74,130.30,128.20,126.72,125.37,125.14,124.36, 122.73,120.93,119.53,117.55,116.17,107.53,83.44,70.24,61.20,49.28,29.48, 27.95,20.58,19.07,15.48,11.60.
HRMS,m/z:calc[M+H]+760.2286,found 760.2287.
核磁和质谱与合成路线的结构式是完全对应的。
实施例2 HYPQG探针在试管里对谷氨酰转肽酶的检测
将HYPQG探针配成1mM的DMSO储备溶液,于-20℃下保存。检测体系为 TBS缓冲溶液(10mM,pH 7.4,含5%的DMSO)。将HYPQG与谷氨酰转肽酶的反应体系在37℃下摇荡30分钟,然后测量其荧光发射光谱。设置荧光仪的激发波长为450nm,发射波长接收范围为580-800nm。其结果如图1所示,从图1可以看出,所述HYPQG探针对谷氨酰转肽酶有很好的响应。
实施例3 HYPQG探针与谷氨酰转肽酶反应产物的形态表征。
反应体系为TBS缓冲溶液(10mM,pH7.4,含5%的DMSO)。将HYPQG探针与谷氨酰转肽酶在37℃下孵育30min后,用DLS测量仪测量生成沉淀的粒径,用扫描电镜拍摄固体颗粒的表面形态,其结果如图2所示。
实施例4 HYPQG探针对活细胞染色成像实验
a)提前将A2780细胞接种在光学培养皿中,每个皿中接种4万个细胞,孵育 24h,然后吸去原有的培养基(1640,含5%FBS和10%双抗),加入DPBS。将所述HYPQG探针与细胞孵育40分钟后,吸去原有的培养基,并用DPBS清洗1次,用激光共聚焦显微镜检测其荧光信号。其结果如图3所示,从图3可以看出,传统的GGT荧光探针在细胞膜上反应后释放的染料很容易扩散进入细胞中,因此不能实现细胞膜上GGT的原位成像,而本专利所述HYPQG探针在细胞膜上反应后形成不溶性沉淀并,因此抑制染料扩散进入细胞,从而能够原位检测细胞膜上的谷氨酰转肽酶。
b)提前将A2780细胞接种在光学培养皿中,每个皿中接种4万个细胞,孵育 24h,然后吸去原有的培养基(1640,含5%FBS和10%双抗),加入DPBS。将所述探针加入细胞中,用激光共聚焦显微镜检测其荧光信号。其结果如图4所示,从图4可以看出,所述HYPQG探针的荧光信号稳定不扩散。
c)提前将A2780,OVCAR3和NIH3T3细胞接种在光学培养皿中,每个皿中接种4万个细胞,孵育24h,然后吸去原有的培养基(1640,含5%FBS和10%双抗),加入DPBS。将所述HYPQG探针与细胞孵育40分钟后,用激光共聚焦显微镜检测其荧光信号。其结果如图5所示,从图5可以看出,相对于传统的荧光探针, HYPQG可以实现对细胞膜表面GGT的原位成像。
d)提前将HepG2细胞接种在光学培养皿中,每个皿中接种4万个细胞,孵育 24h,加入不同浓度的丁酸钠分别培养24h和48h,然后吸去原有的培养基(1640,含5%FBS和10%双抗),加入DPBS。将所述探针加入细胞中,用激光共聚焦显微镜检测其荧光信号。其结果如图6所示,从图6可以看出,HYPQG可以实现对同一种细胞不同状态下细胞膜表面GGT的原位成像。
Claims (8)
2.一种根据权利要求1所述的近红外固态发光的荧光探针的制备方法,包括以下步骤:
(1)将化合物1和乌洛托品溶于三氟乙酸中,加热条件下进行回流反应,反应结束后,加入盐酸进行水解反应,反应结束后,过柱分离后,得到黄色中间体化合物2;
(2)将步骤(1)中的化合物2与2-氨基-5-氯苯甲酰胺及对甲苯磺酸在无水乙醇溶剂中进行回流反应,反应结束并冷却后,向其中加入二氯二氰基苯醌,然后抽滤,得到红色的固体,用乙醇洗涤固体,烘干即得固态荧光染料HYPQ;
(3)将化合物3溶于二氯甲烷中,在冰浴条件下加入DCC,进行初级反应,反应结束后,接着加入2-甲氨基哌啶,并渐渐升温至室温,进行反应,反应完毕后,抽滤掉生成的固体,滤液旋干,饱和碳酸氢钠水溶液洗,二氯甲烷萃取,再调节pH到2~4,产物在水中,再将pH调到11~13,二氯甲烷萃取,旋干,泵0.5~2h,得到化合物4;
(4)在氮气保护下,将步骤(2)中HYPQ溶于无水二氯甲烷和二甲亚砜中,在冰浴条件下中,加入DIPEA,并搅拌混匀,接着加入三光气,常温下搅拌反应,反应完毕后,真空泵抽出未反应的光气;化合物4溶于无水二氯甲烷后加入反应体系,接着加入DIPEA继续反应,反应完毕后,将反应液进行萃取收集有机相,有机相干燥后减压旋蒸去掉萃取溶剂,得到粗产物化合物5,用二氯甲烷重新溶解化合物5,接着向其中加入三氟乙酸脱保护基,刮板提纯产物,得到式Ⅰ所示的近红外固态发光的荧光探针;
合成路线如下:
3.根据权利要求2所述的近红外固态发光的荧光探针的制备方法,其特征在于,所述步骤(1)中,化合物1、乌洛托的物质的量之比为1:(1~1.5),化合物1与三氟乙酸的质量体积比为15~16mg/mL;加热温度为85~95℃,回流反应时间为2~4h;盐酸的浓度为11~13mol/L,相对化合物1的加入量为:150~160mg化合物1加入3~4mL盐酸,水解反应时间为0.5~1.5h;过柱分离采用体积比为5:(3~1)二氯甲烷和石油醚。
4.根据权利要求2所述的近红外固态发光的荧光探针的制备方法,其特征在于,所述步骤(2)中,化合物2、2-氨基-5-氯苯甲酰胺、对甲苯磺酸和二氯二氰基苯醌的物质的量之比为1:(1~1.5):(0.01~0.02):(1.5~3);化合物2与无水乙醇的质量体积比为1~2mg/mL;回流反应时间为2~4h,回流反应温度为80~85℃。
5.根据权利要求2所述的近红外固态发光的荧光探针的制备方法,其特征在于,所述步骤(3)中,化合物3,DCC和2-甲氨基哌啶的物质的量之比为1:(1~1.2):(1~1.1);化合物3与二氯甲烷的质量体积比为3~6mg/mL;初级反应时间为10~20min;反应时间为15~17h。
6.根据权利要求2所述的近红外固态发光的荧光探针的制备方法,其特征在于,所述步骤(4)中,HYPQ,三光气和化合物4的物质的量之比为1:4:(1~1.1);二氯甲烷和二甲亚砜体积比为9~11:1,HYPQ与二氯甲烷和二甲亚砜混合溶剂的质量体积比为0.5~2mg/mL;HYPQ与第一次加入DIPEA的质量体积比为48~50mg/mL,HYPQ与第二次加入DIPEA的质量体积比48~50mg/mL;搅拌混匀时间为9~12min,常温下搅拌反应时间为10~14h;化合物4溶于二氯甲烷后的浓度为8~10mg/mL;继续反应时间为10~14h。
7.根据权利要求1~6中任意一项所述的近红外固态发光的荧光探针在检测体外缓冲液中酶活性中的应用。
8.根据权利要求1~6中任意一项所述近红外固态发光的荧光探针作为检测活细胞中成像细胞膜表面谷氨酰转肽酶活性中检测试剂中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110089529.5A CN112778288B (zh) | 2021-01-22 | 2021-01-22 | 一种近红外固态发光的荧光探针及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110089529.5A CN112778288B (zh) | 2021-01-22 | 2021-01-22 | 一种近红外固态发光的荧光探针及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112778288A true CN112778288A (zh) | 2021-05-11 |
CN112778288B CN112778288B (zh) | 2022-08-09 |
Family
ID=75758669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110089529.5A Active CN112778288B (zh) | 2021-01-22 | 2021-01-22 | 一种近红外固态发光的荧光探针及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112778288B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115925664A (zh) * | 2023-01-06 | 2023-04-07 | 山东省华泰营养健康产业技术研究院有限公司 | 一种具有大斯托克斯位移的近红外荧光探针及其制备方法、应用 |
CN117736135A (zh) * | 2024-02-19 | 2024-03-22 | 西北农林科技大学深圳研究院 | 一种蛋白质位点特异性修饰的方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075916A1 (en) * | 2008-09-05 | 2010-03-25 | Auspex Pharmaceuticals, Inc. | Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases |
CN106632203A (zh) * | 2016-12-19 | 2017-05-10 | 湖南师范大学 | 一种二氰基甲烯基苯并四氢呋喃衍生物及其制备方法 |
CN107033111A (zh) * | 2017-04-21 | 2017-08-11 | 台州学院 | 一种检测硫化氢的近红外荧光探针的合成及应用 |
CN109694372A (zh) * | 2018-12-11 | 2019-04-30 | 湖南大学 | 一种双光子荧光探针及其制备方法与应用 |
CN110156765A (zh) * | 2019-06-09 | 2019-08-23 | 河南师范大学 | 氢键功能化离子液体促进的一锅法制备2-氨基-4h-色烯衍生物的方法 |
CN111253464A (zh) * | 2020-01-06 | 2020-06-09 | 江苏省原子医学研究所 | 一种γ-谷氨酰转肽酶靶向的分子探针及其制备方法和用途 |
-
2021
- 2021-01-22 CN CN202110089529.5A patent/CN112778288B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075916A1 (en) * | 2008-09-05 | 2010-03-25 | Auspex Pharmaceuticals, Inc. | Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases |
CN106632203A (zh) * | 2016-12-19 | 2017-05-10 | 湖南师范大学 | 一种二氰基甲烯基苯并四氢呋喃衍生物及其制备方法 |
CN107033111A (zh) * | 2017-04-21 | 2017-08-11 | 台州学院 | 一种检测硫化氢的近红外荧光探针的合成及应用 |
CN109694372A (zh) * | 2018-12-11 | 2019-04-30 | 湖南大学 | 一种双光子荧光探针及其制备方法与应用 |
CN110156765A (zh) * | 2019-06-09 | 2019-08-23 | 河南师范大学 | 氢键功能化离子液体促进的一锅法制备2-氨基-4h-色烯衍生物的方法 |
CN111253464A (zh) * | 2020-01-06 | 2020-06-09 | 江苏省原子医学研究所 | 一种γ-谷氨酰转肽酶靶向的分子探针及其制备方法和用途 |
Non-Patent Citations (2)
Title |
---|
JUAN OU-YANG等: ""Detecting and Imaging of γ‑Glutamytranspeptidase Activity in Serum, Live Cells, and Pathological Tissues with a High Signal-Stability Probe by Releasing a Precipitating Fluorochrome"", 《ACS SENS.》 * |
PEISHENG ZHANG等: ""A two-photon fluorescent sensor revealing drug-induced liver injury via tracking g-glutamyltranspeptidase (GGT) level in vivo"", 《BIOMATERIALS》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115925664A (zh) * | 2023-01-06 | 2023-04-07 | 山东省华泰营养健康产业技术研究院有限公司 | 一种具有大斯托克斯位移的近红外荧光探针及其制备方法、应用 |
CN115925664B (zh) * | 2023-01-06 | 2023-05-09 | 山东省华泰营养健康产业技术研究院有限公司 | 一种具有大斯托克斯位移的近红外荧光探针及其制备方法、应用 |
CN117736135A (zh) * | 2024-02-19 | 2024-03-22 | 西北农林科技大学深圳研究院 | 一种蛋白质位点特异性修饰的方法 |
CN117736135B (zh) * | 2024-02-19 | 2024-05-07 | 西北农林科技大学深圳研究院 | 一种蛋白质位点特异性修饰的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112778288B (zh) | 2022-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105924394B (zh) | 一种双光子甲醛荧光探针及其制备与应用 | |
CN104086536B (zh) | 一种用于检测pH值的荧光探针及其制备方法与专用检测试剂盒 | |
WO2021103700A1 (zh) | 一种可响应硝基还原酶的乏氧探针化合物及其制备与应用 | |
CN110746410B (zh) | 一种亮氨酸氨肽酶和单胺氧化酶激活的近红外荧光探针、合成方法及生物应用 | |
CN109438319B (zh) | 一种检测亮氨酸氨肽酶的化合物及其制备方法和应用 | |
CN112778288A (zh) | 一种近红外固态发光的荧光探针及其制备方法与应用 | |
CN107367495B (zh) | 一种沉淀型碱性磷酸酶荧光探针及其合成方法和应用 | |
CN110423487B (zh) | 一种Rhodol衍生物染料及其应用 | |
CN115974853A (zh) | 基于苯并半花菁类化合物的荧光探针及其制法和应用 | |
CN113354627B (zh) | 一种用于检测粘度的近红外荧光化合物及其制备与应用 | |
CN110862818A (zh) | 一种γ-谷氨酰转肽酶近红外荧光探针、制备方法及其应用 | |
CN109456250A (zh) | 热激活延迟荧光(tadf)纳米探针及其制备方法和在生物成像中的应用 | |
CN110357817B (zh) | 一类可逆性检测丙酮醛和乙二醛荧光探针及其制备方法和应用 | |
CN110964044B (zh) | 一种基于双香豆素衍生物的过氧化亚硝酸盐荧光探针、制备方法与应用 | |
CN118440066A (zh) | 一种用于检测细胞微环境粘度的荧光探针及其制备方法与专用检测试剂盒 | |
CN116478106B (zh) | 一种检测pH荧光传感器化合物及其制备与应用 | |
CN108383774A (zh) | 一种基于端基炔酮的半胱氨酸荧光探针及其制备和应用 | |
CN110194900B (zh) | 一种发射近红外光的荧光染料及其制备方法 | |
CN109485627B (zh) | 一种香豆素衍生物及其合成方法和在检测硫化氢中的应用 | |
CN117263858A (zh) | 一种双喹啉nadh荧光探针及其制备方法 | |
CN115448928B (zh) | 一种半花菁罗丹明荧光探针及其制备方法和应用 | |
CN110642857A (zh) | 一种用于检测粘度和pH的双功能荧光探针及其制备与应用 | |
CN110357896A (zh) | 一类化合物及制备与其在检测二价铜离子和强酸pH中的应用 | |
Zhao et al. | A novel pH-sensitive hemi-cyanine containing tetrahydropyridine ring near-infrared fluorescence probe with lysosome-targeting ability | |
CN106986782A (zh) | 一种细胞粘度荧光探针及其制备和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |